Kawamura K, Yamasaki T, Zhang Y, Wakizaka H, Hatori A, Xie L
Mol Imaging Biol. 2018; 21(1):105-112.
PMID: 29736564
DOI: 10.1007/s11307-018-1206-y.
Br J Pharmacol. 2008; 109(Suppl):67P-142P.
PMID: 19108269
PMC: 2175552.
Zhang Y, Kimelberg H
Curr Neuropharmacol. 2008; 3(4):317-23.
PMID: 18369397
PMC: 2268994.
DOI: 10.2174/157015905774322534.
Hwang S, Liu I, Tzeng T, Cheng J
Diabetologia. 2005; 48(4):767-75.
PMID: 15756537
DOI: 10.1007/s00125-005-1698-2.
Holt A
J Psychiatry Neurosci. 2003; 28(6):409-14.
PMID: 14631453
PMC: 257786.
RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors.
Clarke R, Harris J
CNS Drug Rev. 2002; 8(2):177-92.
PMID: 12177687
PMC: 6741674.
DOI: 10.1111/j.1527-3458.2002.tb00222.x.
Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction.
Raasch W, Schafer U, Qadri F, Dominiak P
Br J Pharmacol. 2002; 135(3):663-72.
PMID: 11834614
PMC: 1573177.
DOI: 10.1038/sj.bjp.0704513.
Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.
Raasch W, Schafer U, Chun J, Dominiak P
Br J Pharmacol. 2001; 133(6):755-80.
PMID: 11454649
PMC: 1572857.
DOI: 10.1038/sj.bjp.0704153.
Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.
Bruban V, Feldman J, Greney H, Dontenwill M, Schann S, Jarry C
Br J Pharmacol. 2001; 133(2):261-6.
PMID: 11350862
PMC: 1572786.
DOI: 10.1038/sj.bjp.0704080.
Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.
Casanovas A, Olmos G, Ribera J, Boronat M, Esquerda J, Garcia-Sevilla J
Br J Pharmacol. 2000; 130(8):1767-76.
PMID: 10952664
PMC: 1572252.
DOI: 10.1038/sj.bjp.0703485.
Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors.
Sanchez-Blazquez P, Boronat M, Olmos G, Garcia-Sevilla J, Garzon J
Br J Pharmacol. 2000; 130(1):146-52.
PMID: 10781010
PMC: 1572044.
DOI: 10.1038/sj.bjp.0703294.
Non-adrenergic binding of [3H]atipamezole in rat kidney--regional distribution and comparison to alpha2-adrenoceptors.
Sjoholm B, Lahdesmaki J, Pyykko K, Hillila M, Scheinin M
Br J Pharmacol. 1999; 128(6):1215-22.
PMID: 10578134
PMC: 1571757.
DOI: 10.1038/sj.bjp.0702917.
Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes.
Olmos G, Alemany R, Garcia-Sevilla J
Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(6):709-16.
PMID: 8971730
DOI: 10.1007/BF00166896.
Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: implications for stimulus-response coupling of insulin release.
Shepherd R, Hashmi M, Kane C, Squires P, Dunne M
Br J Pharmacol. 1996; 119(5):911-6.
PMID: 8922740
PMC: 1915923.
DOI: 10.1111/j.1476-5381.1996.tb15759.x.
Modulation of sympathetic outflow by centrally acting antihypertensive drugs.
van Zwieten P
Cardiovasc Drugs Ther. 1996; 10 Suppl 1:283-9.
PMID: 8827951
DOI: 10.1007/BF00120498.
A comparative study of the reversal by different alpha 2-adrenoceptor antagonists of the central sympatho-inhibitory effect of clonidine.
Vayssettes-Courchay C, Bouysset F, Cordi A, LAUBIE M, Verbeuren T
Br J Pharmacol. 1996; 117(3):587-593.
PMID: 8821553
PMC: 1909310.
DOI: 10.1111/j.1476-5381.1996.tb15231.x.
No evidence for functional imidazoline receptors on locus coeruleus neurons.
Szabo B, Frohlich R, Illes P
Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(5):557-63.
PMID: 8740150
DOI: 10.1007/BF00169176.
Central imidazoline receptors as a target for centrally acting antihypertensive drugs.
van Zwieten P
Pharm World Sci. 1995; 17(6):186-90.
PMID: 8597774
DOI: 10.1007/BF01870609.
The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine.
Penner S, Smyth D
Br J Pharmacol. 1995; 116(6):2631-6.
PMID: 8590981
PMC: 1909124.
DOI: 10.1111/j.1476-5381.1995.tb17218.x.
Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G, Gabilondo A, Miralles A, Escriba P, Garcia-Sevilla J
Br J Pharmacol. 1993; 108(3):597-603.
PMID: 8385528
PMC: 1908014.
DOI: 10.1111/j.1476-5381.1993.tb12848.x.
